Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 93

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 93
---
 respect of and on behalf of the company) in respect of a cause of action arising from a director’s negligence, default, breach of duty or breach of trust and (ii) a shareholder may bring a claim for a court order where the company’s affairs have been or are being conducted in a manner that is unfairly prejudicial to some of its shareholders. |     | Under Delaware law, a stockholder may initiate                                                                                               
 a derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must:            
 ·     state that                                                                                                                             
 the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiffs shares thereafter     
 devolved on the plaintiff by operation of law; and                                                                                           
 ·     allege with                                                                                                                            
 particularity the efforts made by the plaintiff to obtain the action the plaintiff desires from the directors and the reasons for the        
 plaintiff’s failure to obtain the action; or                                                                                                 
 ·     state the reasons for not making                                                                                                       
 the effort.                                                                                                                                  
 Additionally, the plaintiff must remain a stockholder                                                                                        
 through the duration of the derivative suit. The action will not be dismissed or compromised without the approval of the Delaware Court      
 of Chancery.                                                                                                                                 |

| 60 |

<div align='center'>DESCRIPTION OF AMERICAN DEPOSITARY SHARES</div>

Our
Depositary Shares are deposited pursuant to the Second Amended and Restated Deposit Agreement
dated December 18, 2023, among the Company, JPMorgan Chase Bank, N.A., as depositary, ands
holders and beneficial owners of American Depositary Receipts, as amended from time to time,
or the Deposit Agreement. The depositary registers and delivers the Depositary Shares. Each
Depositary Share represents ownership of 100,000 Ordinary Shares that we will deposit with
the custodian, as agent of the depositary, under the Deposit Agreement.

The depositary’s office is located at 383
Madison Avenue, Floor 11, New York, NY 10179.

The Depositary Share-to-share
ratio is subject to amendment as provided in the form of American Depositary Receipt, or ADR (which may give rise to fees contemplated
by the form of ADR). In the future, each Depositary Share will also represent any securities, cash or other property deposited with the
depositary but which they have not distributed directly to you.

A beneficial owner is any
person or entity having a beneficial ownership interest in Deposit